iPS-Derived Drugs Japan Approval | Osaka U Breakthrough
Explore Japan's historic approval of the first iPS-derived drugs, driven by Osaka University's Cuorips venture. Dive into research, trials, and implications for higher education in biotech.
higher-education-newsjapanese-higher-educationregenerative-medicine
